Published June 5, 2024 | Version v1
Journal article Open

On the Structure, Stability, and Cell Uptake of Nanostructured Lipid Carriers for Drug Delivery

  • 1. University of Graz
  • 2. University of Portsmouth
  • 3. University of Chicago
  • 4. Research Center Pharmaceutical Engineering
  • 5. Medical University of Graz

Description

The efficacy of nanostructured lipid carriers (NLC) for drug delivery strongly depends on their stability and cell uptake. Both properties are governed by their compositions and internal structure. To test the effect of the lipid composition of NLC on cell uptake and stability, three kinds of liquid lipids with different degrees of unsaturation are employed. After ensuring homogeneous size distributions, the thermodynamic characteristics, stability, and mixing properties of NLC are characterized. Then the rates and predominant pathways of cell uptake are determined. Although the same surfactant is used in all cases, different uptake rates are observed. This finding contradicts the view that the surface properties of NLC are dominated by the surfactant. Instead, the uptake rates are explained by the structure of the nanocarrier. Depending on the mixing properties, some liquid lipids remain inside the nanocarrier, while other liquid lipids are present on the surface. Nanocarriers with liquid lipids on the surface are taken up more readily by the cells. This shows that the engineering of efficient lipid nanocarriers requires a delicate balance of interactions between all components of the nanocarrier on the molecular level.

Data availability

The data that support the findings of this study are available within the main text and Supporting Information. Any other relevant data are available from the corresponding author upon request.

Files

jeitler-et-al-2024-on-the-structure-stability-and-cell-uptake-of-nanostructured-lipid-carriers-for-drug-delivery.pdf

Files (10.8 MB)

Name Size Download all
Article
md5:a7cd75bbbcacf997a6319aac4c45daf1
9.9 MB Preview Download
Supporting information
md5:31c2c7e647b1585c169dabc290d69834
894.9 kB Preview Download

Additional details

Identifiers

DOI
10.1021/acs.molpharmaceut.4c00392
Other
oai:uchicago.tind.io:13319

Funding

University of Graz

UChicago Information

Division(s)
Pritzker School of Molecular Engineering